Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology